ArticleParasites & vectors2025
High prevalence of vector-borne pathogens in the blood of clinically healthy dogs in Hong Kong.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Geographical Distribution and Molecular Characterization ofAnimals : an open access journal from MDPI · 2026Article
- Vector-borne pathogens in dogs from different regions of Afghanistan.Parasites & vectors · 2026Article
- The Comparative Study for Detection of Canine Vector-Borne Pathogens Between Companion and Stray Dogs in Bangkok and Vicinities, Thailand.Pathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeishmaniosis and other canine vector-borne diseases (CVBDs) pose a major risk for veterinary and public health globally, especially where humans and dogs live in close proximity. Although mosquito and tick vectors are abundant in Hong Kong, surveillance for CVBDs has been limited.
methodsA serological and molecular survey of 158 healthy owned (n = 64) and free-roaming unowned (n = 94) dogs with outdoor access in Hong Kong was performed to determine CVBD prevalence. Point-of-care (POC) immunoassays were used to detect (i) antibodies to Leishmania spp., Ehrlichia spp., and Anaplasma spp., and (ii) Dirofilaria immitis and Angiostrongylus vasorum antigens, in canine sera. Conventional polymerase chain reaction (PCR) was also carried out to detect the molecular prevalence of all five pathogens as well as Hepatazoon canis, Babesia gibsoni, and Trypanosoma evansi. In addition, for Leishmania spp. detection, an immunofluorescence antibody test (IFAT) was performed on all serum samples, followed by real-time PCR of seropositive samples to detect Leishmania spp. DNA. The agreement between tests was assessed by Cohen's kappa statistic, and logistic regression analysis was applied to identify potential risk factors.
resultsOverall, 45.6% of dogs tested positive on molecular and/or serological tests for at least one pathogen, with the highest prevalence recorded for Dirofilaria spp. (20.9%), followed by B. gibsoni (15.2%), Leishmania spp. (11.4%), Anaplasma spp. (7.6%), H. canis (4.4%), Ehrlichia spp. (3.8%), and A. vasorum (0.6%). No T. evansi DNA was detected. Co-infections or co-pathogen exposure occurred in 16.5% of samples. Of the 33 Dirofilaria spp.-positive dogs, two were identified by sequencing as Dirofilaria asiatica, and the remaining 31 were D. immitis. No significant risk factors for infection or exposure were identified.
conclusionsThis is the first epidemiological survey of Leishmania spp. infection in dogs from Hong Kong, highlighting the need for surveillance of competent vectors and further investigation of disease status in dog populations to confirm whether this pathogen is endemic. Given the high prevalence of CVBD, especially of D. immitis, preventive and control measures are advocated in order to mitigate risks to canine health and zoonotic infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.